110 related articles for article (PubMed ID: 16318951)
1. Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism?
Egli M
Addict Biol; 2005 Dec; 10(4):309-19. PubMed ID: 16318951
[TBL] [Abstract][Full Text] [Related]
2. Schedule-induced alcohol drinking: non-selective effects of acamprosate and naltrexone.
Escher T; Mittleman G
Addict Biol; 2006 Mar; 11(1):55-63. PubMed ID: 16759337
[TBL] [Abstract][Full Text] [Related]
3. A microdialysis study of extracellular levels of acamprosate and naltrexone in the rat brain following acute and repeated administration.
Burattini C; McGeehan AJ; Griffin WC; Gass JT; Kinder JR; Janak PH; Olive MF
Addict Biol; 2008 Mar; 13(1):70-9. PubMed ID: 18269381
[TBL] [Abstract][Full Text] [Related]
4. Advances in the use of naltrexone: an integration of preclinical and clinical findings.
O'Malley SS; Froehlich JC
Recent Dev Alcohol; 2003; 16():217-45. PubMed ID: 12638640
[TBL] [Abstract][Full Text] [Related]
5. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.
Baser O; Chalk M; Rawson R; Gastfriend DR
Am J Manag Care; 2011 Jun; 17 Suppl 8():S222-34. PubMed ID: 21761948
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological relapse prevention of alcoholism: clinical predictors of outcome.
Kiefer F; Helwig H; Tarnaske T; Otte C; Jahn H; Wiedemann K
Eur Addict Res; 2005; 11(2):83-91. PubMed ID: 15785069
[TBL] [Abstract][Full Text] [Related]
7. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
[TBL] [Abstract][Full Text] [Related]
8. What happens when people discontinue taking medications? Lessons from COMBINE.
Stout RL; Braciszewski JM; Subbaraman MS; Kranzler HR; O'Malley SS; Falk D;
Addiction; 2014 Dec; 109(12):2044-52. PubMed ID: 25098969
[TBL] [Abstract][Full Text] [Related]
9. Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators.
Ooteman W; Naassila M; Koeter MW; Verheul R; Schippers GM; Houchi H; Daoust M; van den Brink W
Addict Biol; 2009 Jul; 14(3):328-37. PubMed ID: 19523047
[TBL] [Abstract][Full Text] [Related]
10. Combined therapy: what does acamprosate and naltrexone combination tell us?
Kiefer F; Wiedemann K
Alcohol Alcohol; 2004; 39(6):542-7. PubMed ID: 15456690
[TBL] [Abstract][Full Text] [Related]
11. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.
Rösner S; Leucht S; Lehert P; Soyka M
J Psychopharmacol; 2008 Jan; 22(1):11-23. PubMed ID: 18187529
[TBL] [Abstract][Full Text] [Related]
12. Drugs for relapse prevention of alcoholism: ten years of progress.
Spanagel R; Kiefer F
Trends Pharmacol Sci; 2008 Mar; 29(3):109-15. PubMed ID: 18262663
[TBL] [Abstract][Full Text] [Related]
13. The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics.
Ooteman W; Koeter MW; Verheul R; Schippers GM; van den Brink W
Eur Neuropsychopharmacol; 2007 Jul; 17(8):558-66. PubMed ID: 17379484
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials.
Snyder JL; Bowers TG
Am J Drug Alcohol Abuse; 2008; 34(4):449-61. PubMed ID: 18584575
[TBL] [Abstract][Full Text] [Related]
15. Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study.
Mann K; Kiefer F; Smolka M; Gann H; Wellek S; Heinz A;
Alcohol Clin Exp Res; 2009 Apr; 33(4):674-83. PubMed ID: 19170666
[TBL] [Abstract][Full Text] [Related]
16. Acamprosate for the treatment of alcohol dependence.
Boothby LA; Doering PL
Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
[TBL] [Abstract][Full Text] [Related]
17. Naltrexone and acamprosate. Using new drugs for alcohol dependence.
Tedeschi M
Aust Fam Physician; 2001 May; 30(5):447-50. PubMed ID: 11432017
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic approaches to the management of alcoholism.
Anton RF
J Clin Psychiatry; 2001; 62 Suppl 20():11-7. PubMed ID: 11584870
[TBL] [Abstract][Full Text] [Related]
19. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
[TBL] [Abstract][Full Text] [Related]
20. Acamprosate campral for alcoholism.
Med Lett Drugs Ther; 2005 Jan; 47(1199):1-3. PubMed ID: 15599336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
